This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEC0L0PD_M.jpg
Orbimed Capital’s holding in Arcutis Biotherapeutics, Inc. increased to about 902 thousand shares with the purchase.
Orbimed Capital increased stake in Arcutis Biotherapeutics, Inc.
4 years ago
No Comments
Related Posts
Exclusive-Investcorp revs up to sell Italian motorcycle clothing brand Dainese – sources
December 1, 2021
Netflix shares tumble on report of slow start to ad business
December 15, 2022
GE reports smaller loss as business recovers from pandemic lows
October 28, 2020
Starbucks ‘poised to benefit from China’s reopening’, target hiked at BofA
January 3, 2023
Ex-Trump administration officials target corporate diversity efforts
August 18, 2023
Australia’s Coles posts 1.3% rise in first-quarter sales
October 25, 2022
About The Author
